Search Results - "NADAF, Sorena"
-
1
Precision medicine and actionable alterations in lung cancer: A single institution experience
Published in PloS one (11-02-2020)“…Oncology has become more reliant on new testing methods and a greater use of electronic medical records, which provide a plethora of information available to…”
Get full text
Journal Article -
2
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation
Published in The Journal of immunology (1950) (01-01-2005)“…Impaired Ag-presenting function in dendritic cells (DCs) due to abnormal differentiation is an important mechanism of tumor escape from immune control. A major…”
Get full text
Journal Article -
3
Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
Published in Blood (01-12-1998)“…Defective function of dendritic cells (DC) in cancer has been recently described and may represent one of the mechanisms of tumor evasion from immune system…”
Get full text
Journal Article -
4
Clinical Significance of Defective Dendritic Cell Differentiation in Cancer
Published in Clinical cancer research (01-05-2000)“…Defective dendritic cell (DC) function has been described previously in cancer patients and tumor-bearing mice. It can be an important factor in the escape of…”
Get full text
Journal Article -
5
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo
Published in Blood (01-12-1998)“…Defective function of dendritic cells (DC) in cancer has been recently described and may represent one of the mechanisms of tumor evasion from immune system…”
Get full text
Journal Article -
6
Antibodies to Vascular Endothelial Growth Factor Enhance the Efficacy of Cancer Immunotherapy by Improving Endogenous Dendritic Cell Function
Published in Clinical cancer research (01-10-1999)“…Inadequate function of dendritic cells (DCs) in tumor-bearing hosts is one mechanism of tumor escape from immune system control and may compromise the efficacy…”
Get full text
Journal Article -
7
Immunization With Mutant p53- and K-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome
Published in Journal of clinical oncology (01-08-2005)“…To determine the ability to induce tumor-specific immunity with individual mutant K-ras-or p53-derived peptides and to monitor clinical outcome. Patients in…”
Get full text
Journal Article -
8
Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies
Published in American journal of medical genetics. Part C, Seminars in medical genetics (15-05-2011)“…The RASopathies, one of the largest groups of multiple congenital anomaly syndromes known, are caused by germline mutations in various genes encoding…”
Get full text
Journal Article -
9
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Published in Nature medicine (01-10-1996)“…Inadequate presentation of tumor antigens by host professional antigen-presenting cells (APCs), including dendritic cells (DCs), is one potential mechanism for…”
Get full text
Journal Article -
10
A Training-Testing Approach to the Molecular Classification of Resected Non-Small Cell Lung Cancer
Published in Clinical cancer research (15-10-2003)“…Purpose: RNA expression patterns associated with non-small cell lung cancer subclassification have been reported, but there are substantial differences in the…”
Get full text
Journal Article -
11
PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models
Published in NPJ digital medicine (28-10-2024)“…Clinical trial matching is the task of identifying trials for which patients may be eligible. Typically, this task is labor-intensive and requires detailed…”
Get full text
Journal Article -
12
Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines
Published in Gastroenterology (New York, N.Y. 1943) (01-10-2002)“…Background & Aims: Insulin-like growth factor (IGF)-I receptor (IGF-Ir) signaling is required for maintenance of growth and tumorigenicity of several tumor…”
Get full text
Journal Article -
13
H1° histone and differentiation of dendritic cells. A molecular target for tumor-derived factors
Published in Journal of leukocyte biology (01-08-2002)“…Dendritic cells (DC) play a central role in antitumor immune responses. Abnormal differentiation of DC and their inability to stimulate T cells are important…”
Get full text
Journal Article -
14
A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer
Published in Nature genetics (01-06-1996)“…Tumours express a variety of novel epitopes which represent potential immune targets, and thus clinically evident tumours are thought to have effectively…”
Get full text
Journal Article -
15
Structural and functional analysis of β2 microglobulin abnormalities in human lung and breast cancer
Published in International journal of cancer (17-09-1996)“…The escape of tumor cells from immune recognition is a central problem in tumor immunology. Here, we examined the functional role of somatic beta…”
Get full text
Journal Article -
16
Precision medicine and actionable alterations in lung cancer
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e20707 Background: In recent years, healthcare centers have become more reliant on the advent of new technology, testing methods and a greater…”
Get full text
Journal Article -
17
The City of Hope POSEIDON enterprise-wide platform for real-world data and evidence in cancer
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e18813 Background: The City of Hope Center for Precision Medicine developed an enterprise-wide platform and precision medicine program to unlock…”
Get full text
Journal Article -
18
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
Published in Blood (15-06-2003)“…T-cell defects and premature thymic atrophy occur in cancer patients and tumor-bearing animals. We demonstrate that exposure of mice to recombinant vascular…”
Get full text
Journal Article -
19
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Published in The Lancet (British edition) (09-08-2003)“…Proteomics-based approaches complement the genome initiatives and may be the next step in attempts to understand the biology of cancer. We used matrix-assisted…”
Get full text
Journal Article -
20
Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells
Published in The Journal of immunology (1950) (01-02-1998)“…Vascular endothelial growth factor (VEGF), produced by almost all tumor cells, affects the ability of hemopoietic progenitor cells (HPC) to differentiate into…”
Get full text
Journal Article